Sanofi

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Sanofi
TickerSNY
CIK #0001121404
CUSIP80105N105
SectorLife Sciences
IndustryPharmaceutical Preparations
Phone33153774400
Address54 Rue La Boetie
Paris, 75008
Source [EDGAR]
Market Cap, 13F ($BB)
14011284562802011201320152018
Business

Sanofi is a leading global healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions.

◆ A product is referred to either by its international non-proprietary name (INN) or its brand name, which is generally exclusive to the company that markets it. In most cases, the brand names of our products, which may vary from country to country, are protected by specific registrations. In this document, products are identified by their brand names used in France and/or in the US.

◆ For our Pharmaceuticals activity, unless otherwise stated, all market share percentages and rankings are calculated based on consolidated national pharmaceutical sales data, excluding vaccines and in constant euros, on a September 2018 MAT (Moving Annual Total) basis. The data are mainly from IQVIA local sales audit supplemented by various other country-specific sources including Knobloch (Mexico), GERS (France) and HMR (Portugal).

CIK Filing 2011 - 2021
[0001121404] 3
[0001121404] 4
[0001121404] 6-K
[0001121404] SC 13D
[0001121404] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Sanofi Fulcrum Therapeutics Inc [2019-07-29] 2.4
Sanofi UNUM Therapeutics Inc [2019-02-11] 5.91
Sanofi Ablynx NV [2018-05-25] 5.6
Sanofi Myokardia Inc [2016-02-12] 11.9
Sanofi Voyager Therapeutics Inc [2016-02-12] 0.3
BlackRock Inc Sanofi [2016-02-09] 5.5
Sanofi Immune Design Corp [2014-08-01] 5.8
Sanofi Immune Design Corp [2014-07-31] 5.8
Sanofi Scynexis Inc [2014-05-09] 19.27
Sanofi Alnylam Pharmaceuticals Inc [2014-03-05] 12.0
Sanofi Regeneron Pharmaceuticals Inc [2014-01-14] 16.24
Sanofi Regulus Therapeutics Inc [2012-10-09] 10.99
Sanofi Merrimack Pharmaceuticals Inc [2012-04-02] 5.65
Total SA Sanofi [2012-02-14] 3.22
Form 3/4/5 Filer 2011-2021
Inozyme Pharma Inc
Regeneron Pharmaceuticals Inc
Fulcrum Therapeutics Inc
Myokardia Inc
Alnylam Pharmaceuticals Inc
Voyager Therapeutics Inc
Scynexis Inc
Regulus Therapeutics Inc
Glycomimetics Inc
Kalobios Pharmaceuticals Inc
MM Shares Owned of 2,490.3 MM Total
Firm Period DFND Voting Shares
Dodge & Cox [2020-09-30] SOLE 37.2 39.4
Fisher Asset Management LLC [2020-09-30] DFND 17.7 18.6
FMR LLC [2020-09-30] DFND 0.7 18.2
BlackRock Inc. [2020-09-30] SOLE 12.5 13.4
Bank of America Corp /DE/ [2020-09-30] DFND 0.1 8.6
Invesco Ltd. [2020-09-30] DFND 0.0 6.7
Morgan Stanley [2020-09-30] DFND 2.3 3.6
Hotchkis & Wiley Capital Management LLC [2020-09-30] SOLE 3.2 3.5
Lazard Asset Management LLC [2020-09-30] SOLE 3.0 3.1
Macquarie Group Ltd [2020-09-30] SOLE 2.2 2.9
Parametric Portfolio Associates LLC [2020-09-30] SOLE 1.8 2.1
Wells Fargo & Co/Mn [2020-09-30] DFND 1.7 1.8
Redmile Group LLC [2020-09-30] SOLE 1.7 1.7
PRIMECAP Management Co/Ca/ [2020-09-30] SOLE 1.7 1.7
Royal Bank of Canada [2020-09-30] DFND 1.2 1.5
Artisan Partners Limited Partnership [2020-09-30] SOLE 1.5 1.5
Price T Rowe Associates Inc /MD/ [2020-09-30] SOLE 1.1 1.4
Goldman Sachs Group Inc [2020-09-30] DFND 1.3 1.3
Northern Trust Corp [2020-09-30] DFND 1.0 1.2
Hamlin Capital Management LLC [2020-09-30] SOLE 0.1 1.2
Cambiar Investors LLC [2020-09-30] SOLE 1.2 1.2
Aperio Group LLC [2020-09-30] SOLE 1.1 1.1
Sphera Funds Management Ltd [2020-09-30] DFND 1.1 1.1
Mondrian Investment Partners LTD [2020-09-30] SOLE 0.0 1.1
Northern Trust Corp [2020-09-30] OTR 0.1 1.1
Arrowstreet Capital Limited Partnership [2020-09-30] DFND 0.9 1.1
First Trust Advisors LP [2020-09-30] SOLE 1.0 1.0
Natixis Advisors LP [2020-09-30] DFND 1.0 1.0
Raymond James & Associates [2020-09-30] SOLE 0.8 1.0
Equity Investment Corp [2020-09-30] SOLE 0.9 1.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com